Wednesday, July 8, 2026

biotech · Acute Myeloid Leukemia · Acute Myelogenous Leukemia in Relapse · APTOF

Aptose Biosciences

Aptose Biosciences trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

San Diego, USA HQ
2014 Founded
32 Employees
Public company Type
APTOF · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Founded
2014
Employees
32
Programs
8
Drugs
1
Patents
7
Intelligence · Clinical Trials

Aptose Biosciences clinical trials

Registry index of 8 ClinicalTrials.gov studies linked to Aptose Biosciences programs — each row shows trial ID, program name, phase, status, and indication.

Aptose Biosciences trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Aptose Biosciences.

  1. APTO-253 — Phase 1

    Clinical update
  2. Virulizin® — Phase 3

    Clinical update
  3. GTI-2040 — Phase 2

    Clinical update
  4. GTI-2040 — Phase 2

    Clinical update
  5. Tuspetinib — Phase 2

    Clinical update
  6. CG-806 — Phase 1

    Clinical update
  7. CG-806 — Phase 1

    Clinical update
  8. LOR-253 HCl — Phase 1

    Clinical update

Trial registry

8 studies